» Articles » PMID: 33682781

Bioinformatics Analysis of Myelin Transcription Factor 1

Overview
Publisher Sage Publications
Date 2021 Mar 8
PMID 33682781
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objective: We aimed to further study the role of Myelin Transcription Factor 1(MyT1) in tumor and other diseases and epigenetic regulation, and better understand the regulatory mechanism of MyT1.

Methods: Using bioinformatics analysis, the structure and function of MyT1sequence were predicted and analyzed using bioinformatics analysis, and providing a theoretical basis for further experimental verification and understanding the regulatory mechanism of MyT1. The first, second and third-level structures of MyT1 were predicted and analyzed by bioinformatics analysis tools.

Results: MyT1 is found to be an unstable hydrophilic protein, rather than a secretory protein, with no signal peptide or trans-membrane domain; total amino acids located on the surface of the cell membrane. It contains seven zinc finger domains structurally. At sub-cellular level, MyT1 is localized in the nucleus. The phosphorylation site mainly exists in serine, and its secondary structure is mainly composed of random coils and alpha helices; the three-dimensional structure is analyzed by modeling.

Conclusions: In this study, the structure and function of MyT1 protein were predicted, thereby providing a basis for subsequent expression analysis and functional research; it laid the foundation for further investigation of the molecular mechanism involved in the development of diseases.

Citing Articles

Unraveling the intricacies of glioblastoma progression and recurrence: insights into the role of NFYB and oxidative phosphorylation at the single-cell level.

Liu P, Xing N, Xiahou Z, Yan J, Lin Z, Zhang J Front Immunol. 2024; 15:1368685.

PMID: 38510250 PMC: 10950940. DOI: 10.3389/fimmu.2024.1368685.


Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer.

Li H, Wang L, Zhang W, Dong Y, Cai Y, Huang X Front Oncol. 2023; 12:1002186.

PMID: 36793346 PMC: 9922894. DOI: 10.3389/fonc.2022.1002186.

References
1.
Gamsjaeger R, OConnell M, Cubeddu L, Shepherd N, Lowry J, Kwan A . A structural analysis of DNA binding by myelin transcription factor 1 double zinc fingers. J Biol Chem. 2013; 288(49):35180-91. PMC: 3853269. DOI: 10.1074/jbc.M113.482075. View

2.
Zhang H, Wei M, Jiang Y, Wang X, She L, Yan Z . Reprogramming A375 cells to induced‑resembled neuronal cells by structured overexpression of specific transcription genes. Mol Med Rep. 2016; 14(4):3134-44. PMC: 5042733. DOI: 10.3892/mmr.2016.5598. View

3.
Romm E, Nielsen J, Kim J, Hudson L . Myt1 family recruits histone deacetylase to regulate neural transcription. J Neurochem. 2005; 93(6):1444-53. PMC: 1201409. DOI: 10.1111/j.1471-4159.2005.03131.x. View

4.
Blom N, Sicheritz-Ponten T, Gupta R, Gammeltoft S, Brunak S . Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics. 2004; 4(6):1633-49. DOI: 10.1002/pmic.200300771. View

5.
Pang Z, Yang N, Vierbuchen T, Ostermeier A, Fuentes D, Yang T . Induction of human neuronal cells by defined transcription factors. Nature. 2011; 476(7359):220-3. PMC: 3159048. DOI: 10.1038/nature10202. View